Andreas Pahl

Andreas Pahl

Chief Executive Officer at
Heidelberg Pharma Research GmbH
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Andreas Pahl is a Chief Executive Officer at Simris Biologics GmbH and a Managing Director at Heidelberg Pharma Research GmbH.
Dr. Pahl was previously employed as a Chief Scientific Officer by Heidelberg Pharma AG /Old/, a Chief Executive Officer by Heidelberg Pharma AG, a Member-Supervisory Board by Emergence Therapeutics AG, a Professor-Pharmacology & Toxicology by Friedrich-Alexander University of Erlangen-Nuremberg, a Head-Late Pharmacology by Nycomed GmbH, a Head-Late Pharmacology by Takeda Pharmaceutical Co., Ltd., and a Professor by Technical University of Berlin.
He received his undergraduate degree from Humboldt-Universität zu Berlin.

Andreas Pahl active positions

CompaniesPositionStart
Chief Executive Officer 01/02/2024
Chief Executive Officer 15/07/2026

Former positions of Andreas Pahl

CompaniesPositionEnd
HEIDELBERG PHARMA AG Chief Executive Officer 24/11/2025
Corporate Officer/Principal -
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal -
Director/Board Member -
Corporate Officer/Principal -
See the detail of Andreas Pahl's experience

Training of Andreas Pahl

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

12

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Commercial Services